//
Improving the Use of Primary Prevention Implantable Cardioverter-Defibrillators Therapy With Validated Patient-Centric Risk Estimates
Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes
Randomized Evaluation of Heart Failure With Preserved Ejection Fraction Patients With Acute Heart Failure and Dopamine - The ROPA-DOP Trial
A population-based study of 92 clinically recognised risk factors for heart failure: co-occurrence, prognosis and preventive potential
Proteomics to Improve Phenotyping in Obese Patients with Heart Failure with Preserved Ejection Fraction
The Hospital Readmissions Reduction Program Nationwide Perspectives and Recommendations: A JACC: Heart Failure Position Paper
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Reduced Apolipoprotein M and Adverse Outcomes Across the Spectrum of Human Heart Failure